Skip to main content
Clinical Trials/NCT03805763
NCT03805763UnknownNot Applicable

Clinical Research on the Effect of Different Extents of Internal Limiting Membrane Peeling on Macular Hole Closure and Visual Acuity

Wenzhou Medical University0 sites60 target enrollmentStarted: February 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
60
Primary Endpoint
Mean change from baseline in best-corrected visual acuity (BCVA)

Study Overview

Brief Summary

Observing and describing the surgical effects of different extents of internal limiting membrane peeling combined with internal limiting membrane insertion for macular hole

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Clear diagnosis of macular hole;
  • •The minimum diameter of the macular hole is >400 μm;
  • •Without serious systemic disease that make patients can not be operated;

Exclusion Criteria

  • •suffering from severe retinal diseases such as: diabetic retinopathy, age-related macular degeneration, peripheral retinal detachment, PVR, etc.;
  • •opacitas in the refractive medium can not perform Angio-OCT and visual acuity examination;
  • •eye acute and chronic inflammation, such as acute contagious conjunctivitis, acute and chronic keratitis, acute dacryocystitis;
  • •traumatic macular hole, secondary macular hole, high myopia macular hole, etc.;
  • •having a history of vitrectomy surgery;
  • •glaucoma in stage of preclinical, severe stenosis or closure;

Arms & Interventions

Large extent of ILM Peeling

Experimental

Extent of ILM peeling is 4DD and the ILM flap is inserted

Intervention: Large extent of ILM Peeling (Procedure)

Small extent of ILM Peeling

Experimental

Extent of ILM peeling is 2DD and the ILM flap is inserted

Intervention: Small extent of ILM Peeling (Procedure)

Outcomes

Primary Outcomes

Mean change from baseline in best-corrected visual acuity (BCVA)

Time Frame: 1 year

Assessed using the ETDRS protocol

change from baseline in foveal avascular zone (FAZ) areas and diameter

Time Frame: 1 year

Assessed on AngioOCT

change from baseline in the area and diameter of deteriorated circulation zone in superficial and deep retina vessels

Time Frame: 1 year

Assessed on AngioOCT

Condition of postoperative healing of macular holes

Time Frame: 1 year

postoperative photograph of macular retina scanned by Angiography Optical Coherence Tomography(AngioOCT)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Xiangtian Zhou

Professor

Wenzhou Medical University

Similar Trials